The National Screening Unit (NSU) engaged Health Outcomes International Pty Ltd (HOI) to
conduct an independent evaluation of the implementation of digital mammography (DM) at
Breast Screen Waitemata and Northland (BSWN). The overarching purpose of the evaluation was
to assist the NSU to consider options for the managed introduction of DM into the BreastScreen
Aotearoa (BSA) screening programme, and any implications for national policy and quality
standards that this introduction may have.
This systematic review was conducted to estimate the level of increased breast cancer among women with defined risk factors as requested by the National Screening Unit (NSU), Ministry of Health.
Women who have symptoms of breast cancer are sometimes referred to BreastScreen
Aotearoa (BSA) by their GP, or self refer to the programme. However, this has a
number of risks, including that the breast cancer may not be detected by a
mammogram and that there will be a delay in the diagnosis of breast cancer.
Dr Madeleine Wall, Clinical Leader, BreastScreen Aotearoa.
A report of the Antenatal Down Syndrome Screening Advisory Group to the National Screening Unit, January 2007. Published in March 2007 by the National Screening Unit.
A key objective of the National Cervical Screening Programme (NCSP) is to reduce the incidence of cervical cancer by detecting precancerous high grade squamous intra-epithelial lesions (HSIL). Monitoring trends in HSIL detection is critical to understanding the epidemiology of cervical cancer in New Zealand and to evaluating the performance of the NCSP.